Gesher Acquisition Corp. II

Signal Note: Driehaus Capital Entry into Gesher Acquisition II

Driehaus Capital's $3.3M position in Gesher Acquisition Corp. II (GSHRW) signals conviction in an undisclosed biotech target; Gesher is a blank-check vehicle with no announced merger partner as of this filing date. The timing and size of this growth-stage entry suggests the fund expects either near-term SPAC merger announcement or meaningful clinical/regulatory catalysts within the acquisition target's pipeline.